Ana M. Millan
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: September 15, 2023
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis.
Journal: Journal of personalized medicine
Published: December 05, 2022
Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study.
Journal: Frontiers in medicine
Published: June 20, 2022
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study).
Journal: Rheumatology and therapy
Published: June 02, 2022
Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study).
Journal: Rheumatology and therapy
Published: November 10, 2021
Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease.
Journal: Journal of clinical medicine
Published: March 31, 2021
Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort.
Journal: Clinical immunology (Orlando, Fla.)
Published: September 10, 2020
Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission.
Journal: Mediterranean journal of rheumatology
Published: May 29, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026